{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Preoperative Breast MRI in Breast Cancer: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "This randomised multicentre trial included 440 patients"
      },
      "Participants": {
        "score": 2,
        "evidence": "patients aged 56 years or less with newly diagnosed breast cancer, conducted at three breast cancer units"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised to preoperative MRI (n=220) or conventional imaging (n=220)"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the long-term outcomes of preoperative MRI compared to conventional imaging."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was DFS, measured over a 10-year follow-up."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not applicable."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "randomised to preoperative MRI (n=220) or conventional imaging (n=220) between 2007 and 2010"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "DFS rates were 85.5% in the MRI group and 80.0% in the control group"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "DFS rates were 85.5% in the MRI group and 80.0% in the control group (HR 1.46, 95% CI 0.93 to 2.29; P=0.099)"
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT01859936"
      },
      "Funding": {
        "score": 1,
        "evidence": "Supported by Capio St Goran\u2019s Hospital Research Foundation, Centre for Clinical Research, Vastmanland Hospital, Percy Falk Foundation, and Vastmanland Research Foundation against Cancer."
      }
    },
    "total_score": 21,
    "max_score": 25
  },
  "model": "gpt-4o"
}